case_id,count,combos,patient_info,document_name,Q3_baseline,Q3_rag,Q3_gt
Case3494,12,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_mini_gpt_5', 'top1_10retrieve_gpt_5_gpt_5_mini', 'top1_10retrieve_gpt_5_gpt_5', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","The six-week-old infant was referred by the general pediatrician for genetic evaluation because of a congenital abnormality affecting at least one organ system with concern for an evolving complex neurodevelopmental disorder; no prior genetic testing has been performed, and there is a family history of dysmorphic features in a sibling, so whole exome sequencing (WES) is being requested for diagnostic clarification, genetic counseling was declined by the family, and coverage is through Cigna.",Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,Yes,No,Yes
Case2162,12,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_mini_gpt_5', 'top1_10retrieve_gpt_5_gpt_5_mini', 'top1_10retrieve_gpt_5_gpt_5', 'top1_30retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5_mini', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5_mini', 'top3_30retrieve_gpt_5_gpt_5']","An infant aged 7 weeks was referred by a general practitioner for whole genome sequencing (WGS) to evaluate multiple congenital anomalies affecting multiple organ systems identified at birth; prior Fragile X testing was nondiagnostic, the family history is notable for an older sibling with autism spectrum disorder, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case5674,10,"['top1_10retrieve_gpt_5_mini_gpt_5', 'top1_10retrieve_gpt_5_gpt_5', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5_mini', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","A 9-year-old child with persistent seizures is being evaluated by a general practitioner and has had multiple visits with a genetic counselor; a prior chromosomal microarray (CMA) was nondiagnostic, and the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome given a family history notable for sudden unexplained death in an uncle before age 35, with testing requested under BCBS_FEP and arrangements for post-test follow-up with genetics.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case18821,9,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_mini_gpt_5', 'top1_10retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_gpt_5_mini', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","The obstetrician requests fetal whole exome sequencing (WES) at 22 weeks' gestation after prenatal imaging identified findings concerning for multiple congenital anomalies affecting different organ systems, and the test is intended to evaluate a possible genetic etiology to inform perinatal counseling and management. Family history is notable for a maternal aunt reported to have dysmorphic features. There is no prior genetic testing and no documentation of pre-test genetic counseling, and the patient has coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case13983,7,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5_mini', 'top1_30retrieve_gpt_5_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_10retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","The patient is a 7-week-old infant being evaluated for a high-risk brief resolved unexplained event (BRUE) with a significantly abnormal electrocardiogram (ECG) that raises concern for an underlying channelopathy, arrhythmia, cardiomyopathy, myocarditis, or structural heart disease, and whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist given the concerning cardiac findings and family history. Prior fluorescent in situ hybridization testing was nondiagnostic. The maternal uncle has a history of unexplained developmental regression reported as unrelated to autism or epilepsy and this family history prompted consideration of an inherited etiology. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up, and testing will be billed through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case8485,7,"['top1_30retrieve_gpt_5_mini_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5_mini', 'top3_30retrieve_gpt_5_gpt_5']","An 8-year-old child with hypotonia first noted in infancy is being evaluated by the general pediatrician for persistent motor delay and evolving tone abnormalities, and whole exome sequencing (WES) has been ordered to investigate a possible genetic etiology; prior Fragile X testing was nondiagnostic, the family reports a sibling with autism spectrum disorder, pre-test genetic counseling was not performed, and testing will be submitted with coverage through Cigna.",Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,Yes,No,Yes
Case14017,7,"['top1_10retrieve_gpt_5_mini_gpt_5', 'top1_10retrieve_gpt_5_gpt_5', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","An otherwise healthy 7-week-old infant is being evaluated by the general pediatrician for a high-risk brief resolved unexplained event (BRUE) with recurrent witnessed seizure-like events, and whole exome sequencing (WES) has been ordered to evaluate for a possible genetic etiology. Prior karyotype testing was nondiagnostic. There is a family history of neurologic disease, specifically a maternal uncle reported to have a movement disorder with dystonia and ataxia, and pre-test genetic counseling was completed with plans for post-test follow-up. Testing is being pursued with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case6747,6,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","A 12-year-old child with multiple congenital anomalies is undergoing whole genome sequencing (WGS) ordered by the medical geneticist to evaluate a suspected genetic etiology. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. The family reports a sibling with developmental delay, pre-test counseling has been completed and post-test counseling is planned, and the patient has coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case19162,5,"['top1_10retrieve_gpt_5_mini_gpt_5_mini', 'top1_10retrieve_gpt_5_gpt_5', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","The infant is a neonate presenting with complex neurologic abnormalities including dystonia, ataxia, and asymmetric weakness suggestive of neonatal hemiplegia and was referred by a medical geneticist for whole genome sequencing (WGS) to evaluate for an underlying genetic or metabolic cause. Fragile X testing was previously performed and was nondiagnostic, and there is a family history of an inborn error of metabolism in a sibling. Pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing will be pursued with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,Not Specified,Yes
Case811,4,"['top1_10retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_mini_gpt_5', 'top1_30retrieve_gpt_5_gpt_5', 'top3_10retrieve_gpt_5_mini_gpt_5']","The patient is a 7-week-old infant referred by the general pediatrician for evaluation of early-onset movement abnormalities characterized by dystonia, ataxia and intermittent hemiplegic episodes concerning for a neuromuscular or movement disorder, and chromosomal microarray (CMA) was previously performed and reported as nondiagnostic; given the clinical presentation and a positive family history in an older sibling with multiple congenital anomalies, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology, pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing is being ordered with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case8051,4,"['top1_10retrieve_gpt_5_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5_mini', 'top3_10retrieve_gpt_5_mini_gpt_5_mini', 'top3_30retrieve_gpt_5_gpt_5_mini']","An infant of 5 weeks with a major congenital cardiac anomaly is being evaluated with whole exome sequencing (WES) ordered by the family medicine physician, and prior fluorescence in situ hybridization testing was nondiagnostic; the history is notable for a mother with short stature raising concern for a growth-related genetic condition, the family completed pre-test genetic counseling and will follow up after results, and testing is being pursued to clarify the etiology of the cardiac defect and potential syndromic associations with billing through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case2666,3,"['top1_10retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5_mini']","A 21-year-old woman with a major congenital cardiac anomaly is undergoing BRCA1/2 testing at the request of her obstetrician, and prior fluorescence in situ hybridization (FISH) testing was nondiagnostic; she reports a father with metastatic prostate cancer prompting consideration of hereditary cancer evaluation, pre-test counseling was completed with a genetic specialist and plans for post-test follow-up are in place, and she has coverage through the Blue Cross Blue Shield Federal Employee Program (FEP).",BCBS_FEP_20402 Germline Genetic Testing for.pdf,No,Yes,No
Case2847,3,"['top1_10retrieve_gpt_5_gpt_5', 'top3_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","A 5-week-old infant was referred by cardiology after a high-risk brief resolved unexplained event that required cardiopulmonary resuscitation, and whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. There is a family history of the mother having a persistent and severe immunologic or hematologic disorder, and the family has coverage through BCBS FEP. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case11795,2,"['top1_30retrieve_gpt_5_mini_gpt_5', 'top3_30retrieve_gpt_5_gpt_5']","The patient is a three-week-old infant referred by a cardiologist for evaluation of a high-risk brief resolved unexplained event (BRUE) with a markedly abnormal electrocardiogram concerning for channelopathy, significant arrhythmia, cardiomyopathy, myocarditis, or structural heart disease. Chromosomal microarray (CMA) was previously performed and was nondiagnostic, so whole exome sequencing (WES) is being ordered to evaluate for an underlying genetic cause. There is a family history of a sibling with moderate to severe intellectual disability diagnosed in childhood, pre-test genetic counseling has been completed with plans for post-test follow-up, and testing will be billed through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case7447,2,"['top1_30retrieve_gpt_5_mini_gpt_5_mini', 'top1_30retrieve_gpt_5_mini_gpt_5']","At 33 weeks' gestation, fetal imaging raises concern for an isolated severe congenital heart defect and the cardiologist has ordered whole genome sequencing (WGS) to evaluate for a possible genetic etiology and to guide postnatal management; prior fragile X testing was nondiagnostic, family history is notable for a maternal aunt with triple-negative breast cancer, there is no documentation of pre-test genetic counseling, and coverage is through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case10075,1,['top1_10retrieve_gpt_5_mini_gpt_5_mini'],"A four-week-old infant was seen by a developmental pediatrician for meconium ileus and consideration of chromosomal microarray (CMA) testing to evaluate for an underlying chromosomal or genetic etiology. Prior chromosomal microarray testing was nondiagnostic and there is a family history of an inborn error of metabolism in a sibling, raising concern for a heritable disorder. Pre-test counseling was completed with a genetic specialist and arrangements for post-test follow-up were discussed, and testing will be pursued with coverage through BCBS_FEP.",BCBS_FEP_20459 Genetic Testing for Developmental.pdf,Not Specified,No,Not Specified
Case13,1,['top1_30retrieve_gpt_5_gpt_5'],"The newborn is being evaluated by the general pediatrician for multiple congenital anomalies that do not fit a well-delineated genetic syndrome and has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, pre-test genetic counseling was completed and post-test follow-up is planned, and testing will be submitted with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case14226,1,['top1_10retrieve_gpt_5_mini_gpt_5_mini'],"A 55-year-old patient is being evaluated by oncology for germline BRCA1 and BRCA2 (BRCA1/2) testing because they have a personal history of a primary solid tumor other than basal or squamous cell skin cancer and risk assessment using Tyrer-Cuzick, BRCAPro, or Penn II calculators demonstrates a 2.5% or greater likelihood of a BRCA pathogenic variant; the patient has not undergone prior genetic testing and no pre-test genetic counseling was completed, and family history is notable for a mother with a persistent, severe hematologic or immunologic disorder, with testing being pursued with coverage through Cigna and results to be reviewed by the oncology team to inform management.",Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,No,Not Specified,No
